Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

40%

Ph phase_3

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

3(60.0%)

N/ANon-phased studies

2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Other(1)

Detailed Status

Completed3

Withdrawn1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 33 (60.0%)

N/A2 (40.0%)

Trials by Status

completed360%

withdrawn120%

unknown120%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study

NCT01798329

completedphase_3

A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.

NCT00175292

Clinical Trials (5)

Showing 5 of 5 trials

NCT03533621Not Applicable

Gut Microbiome, Adiposity, and Probiotics (GMAP)

Completed

NCT03330678Not Applicable

Effect of Probiotic Administration on Gut Flora Composition

Completed

NCT02545413Phase 3

Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome

Withdrawn

NCT01798329Phase 3

ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study

Unknown

NCT00175292Phase 3

A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5